National HealthCare Corporation filings document operating results, dividend actions, governance matters and capital-structure disclosures for a publicly traded senior health care company. The company’s 8-K reports include earnings releases, quarterly common dividend announcements, director appointments and other material-event disclosures, with NHC common stock registered on the NYSE American.
Proxy materials cover annual meeting matters, shareholder voting, board structure and committee governance. The filing record also describes NHC’s skilled nursing, senior living, behavioral health, home care, hospice, pharmacy, rehabilitation and third-party management activities, along with financial reporting topics such as GAAP and non-GAAP results, marketable equity securities and acquired White Oak operations.
National Healthcare Corp senior executive exercises stock options and settles taxes in shares
Timothy J. Shelly, Sr. VP Operations of National Healthcare Corp, exercised options to purchase 2,667 and 3,667 shares of common stock on March 4, 2026. These options were granted under the 2020 Omnibus Equity Incentive Plan, as noted in the footnotes.
In connection with these exercises, 4,481 shares of common stock were withheld by the company to pay the option exercise price and related tax obligations. After these transactions, Shelly held 3,147 shares of common stock directly, along with 2,400 and 14,000 options to purchase common stock.
National Healthcare Corp (NHC) senior vice president and CFO Brian F. Kidd reported option exercises and related share withholdings in company stock. On March 4, 2026, he exercised options for 2,000 shares of common stock at $53.94 per share and 4,000 shares at $90.62 per share under the 2020 Omnibus Equity Incentive Plan. The filing shows a tax-related disposition of 3,947 shares of common stock at $172.83 per share, with shares withheld by the company to pay the exercise price and withholding taxes. Following these transactions, Kidd beneficially owned 27,277 shares of common stock and held options to purchase 8,000 and 14,000 shares, all as direct ownership.
NATIONAL HEALTHCARE CORP director David R. Gifford filed an initial statement of beneficial ownership on Form 3. The filing identifies him as a director of the company and, based on the structured data, shows no reported insider purchase, sale, acquisition, or disposition transactions at this time.
Dodson Vicki L reported acquisition or exercise transactions in this Form 4 filing.
National Healthcare Corp senior vice president Vicki L. Dodson received an equity award of 1,082 shares of common stock. The award was granted at no cash cost to her and increased her directly held common stock to 11,371.5455 shares.
The 1,082 shares are restricted stock that vest over three years. One-third is scheduled to vest on January 1, 2027, another third on January 1, 2028, and the final third on January 1, 2029, encouraging longer-term alignment with the company.
Shelly Timothy J. reported acquisition or exercise transactions in this Form 4 filing.
National Healthcare Corp senior vice president of operations Timothy J. Shelly received an equity award of 1,294 shares of common stock on February 27, 2026. The award was granted at $0.00 per share, indicating a stock-based compensation grant rather than an open-market purchase.
The granted shares are restricted and follow a three-year vesting schedule. One-third of the award is scheduled to vest on January 1, 2027, another third on January 1, 2028, and the final third on January 1, 2029. The filing also lists existing stock options, showing post-transaction holdings of 2,400, 8,000, 11,000, and 14,000 options under various grants, all held directly.
National Healthcare Corp CEO Stephen Fowler Flatt reported several equity transactions involving company stock. He exercised options to acquire 5,000 shares of common stock on March 2, 2026, at an exercise price effectively recorded as $0.0000 per option, increasing his directly held common shares to 67,237.
As part of the same event, 3,585 shares of common stock were withheld by the company at a price of $171.1500 per share to cover tax obligations, reducing his direct holdings to 63,652 shares. The filing also shows updated direct holdings of multiple option grants under the 2020 Omnibus Equity Incentive Plan, with post-transaction option positions of 6,147, 10,000 and 20,000 options.
Flatt Stephen Fowler reported acquisition or exercise transactions in this Form 4 filing.
National Healthcare Corp CEO Stephen Fowler Flatt was granted 3,090 shares of common stock on February 27, 2026, as a stock award with no cash paid per share. The grant consists of restricted shares subject to a three-year vesting schedule.
The award vests in three equal installments of 33 1/3% on January 1 of 2027, 2028, and 2029. The Form 4 also reports several option-to-purchase-common-stock positions, with post-transaction holdings of 6,147, 10,000, 18,000, and 20,000 option shares held directly.
National Healthcare Corp reported that SVP and CFO Brian F. Kidd acquired 1,507 shares of common stock on a grant or award basis at $0.00 per share. Following this grant, his directly held common stock totals 25,224 shares.
The footnote explains these are restricted shares that vest over three years, with 33 1/3% vesting on 1/1/2027, another 33 1/3% on 1/1/2028, and the final 33 1/3% on 1/1/2029. The filing also lists existing options to purchase common stock held directly.
National Healthcare Corp reported that Senior VP & General Counsel Josh A. McCreary acquired 1,458 shares of common stock on a restricted basis. These restricted shares vest over three years, in equal 33 1/3% installments on January 1 of 2027, 2028, and 2029. Following this grant, he directly holds 11,400 common shares, along with multiple option awards to purchase common stock reported as existing holdings.
FLATT BEN ANDERSON SR reported acquisition or exercise transactions in this Form 4 filing.
National Healthcare Corp senior vice president and CIO Ben Anderson Flatt Sr. received a grant of 1,342 shares of common stock on February 27, 2026. These are restricted shares granted at $0.00 per share, increasing his directly held common stock to 15,459.0547 shares after the award.
The restricted shares vest over three years, with 33 1/3% vesting on January 1, 2027, another 33 1/3% on January 1, 2028, and the final 33 1/3% on January 1, 2029. The filing also reports option holdings to purchase common stock, with several option positions listed as directly owned holdings.